These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7930786)

  • 21. Precautions with gentian violet: skin marking made sterile, effective, and economical.
    Chen TM; Castaneda M; Wanitphakdeedecha R; Nguyen TH; Tarrand JJ; Soares MK
    Am J Infect Control; 2009 Apr; 37(3):244-6. PubMed ID: 18922601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa.
    Pepeljnjak S; Kosalec I
    FEMS Microbiol Lett; 2004 Nov; 240(1):111-6. PubMed ID: 15500987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of synergistic enhancement of antimicrobial activities of piperacillin and amikacin against Pseudomonas aeruginosa using FIC index and disc diffusion method].
    Uete T; Matsuo K
    Jpn J Antibiot; 1990 Sep; 43(9):1572-8. PubMed ID: 2124633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A; Marty N; Henry S; Agueda L; Chabanon G
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent.
    Chaiban G; Hanna H; Dvorak T; Raad I
    J Antimicrob Chemother; 2005 Jan; 55(1):51-6. PubMed ID: 15574478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of macrolide antibiotics on human serum-bactericidal sensitivity of Pseudomonas aeruginosa S-6].
    Tateda K; Furuya N; Hirakata Y; Ohno A; Kaneko Y; Miyazaki S; Tsuji A; Yamaguchi K; Goto S
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1337-43. PubMed ID: 1838760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamics of Aerosolized Fosfomycin and Amikacin against Resistant Clinical Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae in a Hollow-Fiber Infection Model: Experimental Basis for Combination Therapy.
    Sime FB; Johnson A; Whalley S; Santoyo-Castelazo A; Montgomery AB; Walters KA; Lipman J; Hope WW; Roberts JA
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adaptation process of Pseudomonas aeruginosa to didecyldimethylammonium chloride in 2-propanol on bactericidal efficiency of this active substance.
    Chojecka A; Wiercińska O; Röhm-Rodowald E; Kanclerski K; Jakimiak B
    Rocz Panstw Zakl Hig; 2014; 65(4):359-64. PubMed ID: 25526583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental test of the bacteriostatic and bactericidal effect of six disinfectants for Pseudomonas aeruginosa].
    Zhang XL; Sun YL; Mi LY
    Zhonghua Hu Li Za Zhi; 1995 Dec; 30(12):707-8. PubMed ID: 8716646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial synergism of piperacillin and gentamicin against pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis.
    Bach VT; Webb DW; Thadepalli H
    Chemotherapy; 1980; 26(1):21-7. PubMed ID: 6766372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of merbromin in the treatment of varicose bacterial eczema and fungal affection of the feet. I. Bactericidal and antimycotic effects of merbromin].
    Beránek J; Tomsíková A; Pauleová E
    Cesk Dermatol; 1968 Aug; 43(4):236-42. PubMed ID: 4971331
    [No Abstract]   [Full Text] [Related]  

  • 36. [Bactericidal activities of isepamicin and ofloxacin against Pseudomonas aeruginosa evaluated using an in vitro pharmacokinetic simulation system].
    Tsuji A; Kaneko Y; Yamaguchi K; Goto S
    Jpn J Antibiot; 1994 Aug; 47(8):1006-12. PubMed ID: 7933530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical gentian violet for cutaneous infection and nasal carriage with MRSA.
    Okano M; Noguchi S; Tabata K; Matsumoto Y
    Int J Dermatol; 2000 Dec; 39(12):942-4. PubMed ID: 11168669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
    Weinstein RJ; Young LS; Hewitt WL
    J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
    Chan E; Zhou S; Srikumar S; Duan W
    Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa. In vitro synergistic activities].
    Iyama Y; Sato K; Okachi R
    Jpn J Antibiot; 1985 Apr; 38(4):1022-8. PubMed ID: 3928940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.